Skip to Content

Logo 5623 150 mg (Nizatidine 150 mg)

Pill with imprint Logo 5623 150 mg is White & Yellow, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Teva Pharmaceuticals USA.

Nizatidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; indigestion; duodenal ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 5623 150 mg

Nizatidine 150 mg Logo 5623 150 mg

Nizatidine

Imprint
Logo 5623 150 mg
Strength
150 mg
Color
White & Yellow
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00172-5623

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.